113 related articles for article (PubMed ID: 7534976)
1. Neoadjuvant chemotherapy for advanced nasopharyngeal carcinoma.
Lin JC; Jan JS; Hsu CY
Am J Clin Oncol; 1995 Apr; 18(2):139-43. PubMed ID: 7534976
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
3. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
;
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
Park KH; Kim JS; Park Y; Seo HY; Park YJ; Choi IK; Oh SC; Seo JH; Kim CY; Jung KY; Shin SW; Kim YH; Kim JS; Lee NJ
Cancer Chemother Pharmacol; 2010 Sep; 66(4):643-51. PubMed ID: 20033411
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
[TBL] [Abstract][Full Text] [Related]
9. High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma.
Onat H; Basaran M; Esassolak M; Bavbek SE; Anacak Y; Kaytan E; Altun M; Haydaroglu A
Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):449-54. PubMed ID: 12512965
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
12. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
[TBL] [Abstract][Full Text] [Related]
13. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.
Chua DT; Sham JS; Wei WI; Ho WK; Au G; Choy D
Head Neck; 2002 Apr; 24(4):350-60. PubMed ID: 11933177
[TBL] [Abstract][Full Text] [Related]
14. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation.
Rischin D; Corry J; Smith J; Stewart J; Hughes P; Peters L
J Clin Oncol; 2002 Apr; 20(7):1845-52. PubMed ID: 11919243
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
19. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
